Venous Leg Ulcers Clinical Trial
Official title:
A Prospective, Randomized Clinical Trial of PRP Concepts Fibrin Bio-Matrix in Chronic Non-Healing Venous Leg Ulcers
To assess the efficacy of the PRP Concepts Fibrin Bio-Matrix and compare its performance with usual and customary practice for the treatment of chronic non-healing venous leg ulcers (VLU).
This is a prospective, randomized, single-blind, controlled, multi-center study for subjects undergoing VLU treatment. Qualified subjects will be randomized (1:1); test group (PRP Concepts Fibrin Bio-Matrix) and control group (usual and customary practice). The study will consist of 3 periods: a screening period, an active treatment period, and a follow-up period (if healed). Approximately 250 subjects will be enrolled. Subjects will be ≥18 years of age with a VLU (greater than 4 weeks duration). Each subject will be enrolled in the active treatment period for up to 12 weeks, or to closure of wound with a confirmatory visit 2 weeks after wound closure, whether such closure occurs at 12 weeks or earlier. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00663091 -
A Prospective, Randomized, Double-Blind Controlled Study of WPP-201 for the Safety and Efficacy of Treatment of Venous Leg Ulcers
|
Phase 1 | |
| Recruiting |
NCT02609594 -
Amnioband and Standard of Care vs. Standard of Care Alone in the Treatment of Venous Leg Ulcers
|
N/A | |
| Unknown status |
NCT02011724 -
A Study Of Pain And Quality Of Life Outcomes In Subjects With a Single Painful Venous Leg Ulcer Treated With Apligraf®
|
Phase 4 | |
| Active, not recruiting |
NCT01737762 -
Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm2 to ≤ 36 cm2
|
Phase 3 | |
| Completed |
NCT02222467 -
Safety Evaluation of the KLOX BioPhotonic System in Venous Leg Ulcers
|
N/A | |
| Completed |
NCT01199588 -
A Study to Investigate the Efficacy, Safety and Tolerability of Nexagon® as a Topical Treatment for Subjects With Venous Leg Ulcers
|
Phase 2 | |
| Withdrawn |
NCT00953563 -
The Mechanism of Action of Unite Biomatrix in Venous Leg Ulcers
|
N/A | |
| Enrolling by invitation |
NCT02047084 -
Comparison of Human Allograft to Apligraf for Venous Leg Ulcers
|
||
| Completed |
NCT02020746 -
Efficacy and Safety Study of EscharEx to Treat (Debride) Hard to Heal Wounds
|
Phase 2 | |
| Terminated |
NCT02154087 -
A Phase 2 Exploratory Pharmacodynamic Study of HP802-247 in Venous Leg Ulcers
|
Phase 2 | |
| Completed |
NCT02470806 -
Single-Use Negative Pressure Wound Therapy System vs. Traditional Negative Pressure Wound Therapy System (tNPWT)
|
N/A | |
| Suspended |
NCT02577120 -
Wound Healing Endpoint and Recurrence
|
Phase 4 | |
| Completed |
NCT01743053 -
A Pilot Trial of the Use of ReCell® Autologous Cell Harvesting Device for Venous Leg Ulcers
|
Phase 4 | |
| Recruiting |
NCT02352454 -
Effectiveness of Aurix Therapy in Venous Leg Ulcers
|
N/A | |
| Withdrawn |
NCT02940587 -
Effectiveness of Aurix Therapy in Venous Leg Ulcers
|
Phase 4 | |
| Completed |
NCT01036438 -
Evaluating the Efficacy of an Absorbent Foam Dressing Containing Silver (Mepilex Ag) Versus the Same Dressing Without Silver Used on Subjects With Venous Leg Ulcers or Mixed Ulcers
|
Phase 4 | |
| Unknown status |
NCT02224300 -
Nursing Care With Patients With Venous Leg Ulcers
|
Phase 2 | |
| Completed |
NCT01656889 -
Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers
|
Phase 3 | |
| Completed |
NCT02422017 -
Topical Timolol Benefit in Venous Ulcers
|
Phase 2 |